|
Market Closed -
Xetra
11:35:52 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 379.85 EUR | +1.12% |
|
-1.05% | +3.69% |
| 09-11 | Arizona accuses L'Oreal of concealing cancer risks linked to hair relaxers | RE |
| 09-10 | L'Oreal briefly becomes the CAC 40's top market cap |  |
Company Valuation: L'Oréal
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 232,521 | 178,538 | 240,974 | 182,877 | 195,473 | 202,227 | - | - |
| Change | - | -23.22% | 34.97% | -24.11% | 6.89% | 3.46% | - | - |
| Enterprise Value (EV) 1 | 231,489 | 181,571 | 245,378 | 187,319 | 197,524 | 210,555 | 207,794 | 204,584 |
| Change | - | -21.56% | 35.14% | -23.66% | 5.45% | 6.6% | -1.31% | -1.54% |
| P/E | 50.8x | 31.4x | 39.1x | 28.6x | 32x | 29.1x | 26.1x | 23.9x |
| PBR | 9.9x | 6.57x | 8.32x | 5.52x | 5.6x | 5.4x | 4.94x | 4.51x |
| PEG | - | 1.1x | 4.56x | 7.66x | -7.5x | 2.1x | 2.2x | 2.64x |
| Capitalization / Revenue | 7.2x | 4.67x | 5.85x | 4.21x | 4.44x | 4.3x | 4.05x | 3.82x |
| EV / Revenue | 7.17x | 4.75x | 5.96x | 4.31x | 4.48x | 4.48x | 4.17x | 3.87x |
| EV / EBITDA | 29.1x | 20.2x | 24.9x | 17.8x | 18.4x | 18.5x | 17x | 15.7x |
| EV / EBIT | 37.6x | 24.3x | 30.1x | 21.6x | 22.2x | 21.9x | 20x | 18.4x |
| EV / FCF | 40.9x | 36.7x | 40x | 28.1x | 27.6x | 29.1x | 25.9x | 23.8x |
| FCF Yield | 2.44% | 2.72% | 2.5% | 3.55% | 3.63% | 3.43% | 3.86% | 4.21% |
| Dividend per Share 2 | 4.8 | 6 | 6.6 | 6.667 | 7.2 | 7.766 | 8.37 | 9.031 |
| Rate of return | 1.15% | 1.8% | 1.46% | 1.95% | 1.96% | 2.04% | 2.2% | 2.38% |
| EPS 2 | 8.21 | 10.61 | 11.52 | 11.95 | 11.44 | 13.03 | 14.57 | 15.89 |
| Distribution rate | 58.5% | 56.6% | 57.3% | 55.8% | 62.9% | 59.6% | 57.5% | 56.8% |
| Net sales 1 | 32,288 | 38,261 | 41,182 | 43,487 | 44,052 | 46,982 | 49,884 | 52,891 |
| EBITDA 1 | 7,941 | 8,993 | 9,858 | 10,543 | 10,709 | 11,378 | 12,198 | 13,037 |
| EBIT 1 | 6,160 | 7,457 | 8,143 | 8,688 | 8,892 | 9,600 | 10,367 | 11,103 |
| Net income 1 | 4,597 | 5,707 | 6,184 | 6,409 | 6,127 | 6,980 | 7,771 | 8,422 |
| Net Debt 1 | -1,033 | 3,033 | 4,404 | 4,443 | 2,051 | 8,328 | 5,567 | 2,357 |
| Reference price 2 | 416.95 | 333.60 | 450.65 | 341.85 | 366.60 | 379.85 | 379.85 | 379.85 |
| Nbr of stocks (in thousands) | 557,672 | 535,187 | 534,725 | 534,962 | 533,205 | 532,387 | - | - |
| Announcement Date | 2/9/22 | 2/9/23 | 2/8/24 | 2/6/25 | 2/12/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.15x | 4.48x | 18.51x | 2.04% | 235B | |
| 50.5x | 7.22x | 27.75x | 0.25% | 44.29B | |
| 24.03x | 4.38x | 16.99x | 1.38% | 10.39B | |
| 30.59x | 1.56x | 11.56x | 1.79% | 8.86B | |
| 23.54x | 1.69x | 10.89x | 1.15% | 6.47B | |
| 52.45x | 3.18x | 15.5x | -.--% | 5.72B | |
| 22.92x | 2.32x | 12.43x | 2.86% | 3.59B | |
| 12.03x | 1.48x | 8.1x | 3.89% | 3.34B | |
| 21.08x | 2.78x | 13.33x | 3.53% | 2.88B | |
| Average | 29.59x | 3.23x | 15.01x | 1.88% | 35.58B | |
| Weighted average by Cap. | 31.96x | 4.63x | 19.11x | 1.75% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- OR Stock
- LOR Stock
- Valuation L'Oréal
Select your edition
All financial news and data tailored to specific country editions
